JP2004507521A5 - - Google Patents

Download PDF

Info

Publication number
JP2004507521A5
JP2004507521A5 JP2002523448A JP2002523448A JP2004507521A5 JP 2004507521 A5 JP2004507521 A5 JP 2004507521A5 JP 2002523448 A JP2002523448 A JP 2002523448A JP 2002523448 A JP2002523448 A JP 2002523448A JP 2004507521 A5 JP2004507521 A5 JP 2004507521A5
Authority
JP
Japan
Prior art keywords
embedded image
compound according
compound
phenylazo
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002523448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004507521A (ja
JP5112595B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/041910 external-priority patent/WO2002018330A1/en
Publication of JP2004507521A publication Critical patent/JP2004507521A/ja
Publication of JP2004507521A5 publication Critical patent/JP2004507521A5/ja
Application granted granted Critical
Publication of JP5112595B2 publication Critical patent/JP5112595B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002523448A 2000-08-29 2001-08-28 抗炎症活性および抗生物質活性を有する５−ａｓａ誘導体およびこれを用いて疾患を治療する方法 Expired - Fee Related JP5112595B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22868200P 2000-08-29 2000-08-29
US60/228,682 2000-08-29
PCT/US2001/041910 WO2002018330A1 (en) 2000-08-29 2001-08-28 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith

Publications (3)

Publication Number Publication Date
JP2004507521A JP2004507521A (ja) 2004-03-11
JP2004507521A5 true JP2004507521A5 (enExample) 2008-10-02
JP5112595B2 JP5112595B2 (ja) 2013-01-09

Family

ID=22858177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002523448A Expired - Fee Related JP5112595B2 (ja) 2000-08-29 2001-08-28 抗炎症活性および抗生物質活性を有する５−ａｓａ誘導体およびこれを用いて疾患を治療する方法

Country Status (10)

Country Link
US (1) US6458776B1 (enExample)
EP (1) EP1313699B1 (enExample)
JP (1) JP5112595B2 (enExample)
AT (1) ATE460394T1 (enExample)
AU (1) AU2001285489A1 (enExample)
CA (1) CA2421114C (enExample)
DE (1) DE60141520D1 (enExample)
IL (2) IL154537A0 (enExample)
MX (1) MXPA03001786A (enExample)
WO (1) WO2002018330A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2333337T3 (es) 2000-08-29 2010-02-19 Biocon Limited Uso de una composicion farmaceutica que contiene un derivado de acido para-aminofenilacetico para tratar afecciones inflamatorias del tracto gastrointestinal.
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20050191302A1 (en) * 2002-08-29 2005-09-01 University Of Southampton Treatment for liver disease
EP1603556A2 (en) * 2003-03-06 2005-12-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Sod mimic multifunctional compounds for treating inflammatory bowel disease
SE523093C2 (sv) * 2003-03-25 2004-03-30 Sven Kindblom Stötdämpare för höjdreglering
US7749954B2 (en) 2003-07-23 2010-07-06 Novartis Ag Use of calcitonin in osteoarthritis
AU2005209948B2 (en) 2004-02-06 2009-09-10 Pharmatel (R&D) Pty Limited Use of aminosalicylates in diarrhoea-predominent Irritable Bowel Syndrome
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
WO2006125293A1 (en) 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US7498355B2 (en) 2005-05-27 2009-03-03 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US20060270635A1 (en) * 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
US7741359B2 (en) * 2005-05-27 2010-06-22 Antibe Therapeutics Inc. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN102670626A (zh) * 2005-08-24 2012-09-19 萨利克斯药品公司 巴柳氮制剂及其生产和应用
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US20080255048A1 (en) 2005-11-17 2008-10-16 Moise Azria Pharmaceutical Composition
CN101594885B (zh) * 2006-03-09 2017-07-18 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
CN101489986A (zh) * 2006-06-06 2009-07-22 安泰碧治疗公司 曲美布汀和n-去甲基曲美布汀的盐
US7271253B1 (en) * 2006-08-10 2007-09-18 Apotex Pharmachem Inc. Safe process for the preparation of balsalazide
JPWO2008114831A1 (ja) * 2007-03-20 2010-07-08 国立大学法人 岡山大学 スルホンアミド基を有する抗菌剤
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
CA2721981A1 (en) * 2008-05-01 2009-11-05 The Procter & Gamble Company Methods and kits for the treatment of inflammatory bowel disorder conditions
CN105348184B (zh) * 2015-11-26 2020-12-29 苏州统华药品有限公司 一种柳氮磺吡啶的制备方法
JP7377791B2 (ja) 2017-07-07 2023-11-10 エピセントアールエックス，インコーポレイテッド 治療剤の非経口投与のための組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2270676A (en) * 1936-08-20 1942-01-20 Winthrop Chem Co Inc Sulphonic acid amide compound
US2396145A (en) * 1940-12-14 1946-03-05 Pharmscia Ab Heterocyclic sulphonamido azo compounds
BE791889A (fr) * 1971-11-26 1973-05-24 Pharmacia Ab Nouveaux derives de la pyridine
JPS5353449A (en) * 1976-10-22 1978-05-15 Sofuia Kk Picture type pachinko game machine
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
CS142691A3 (en) * 1991-05-15 1992-11-18 Vyzk Ustav Farm Biochem Sp Process for preparing 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/-acetylsalicylic acid
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation

Similar Documents

Publication Publication Date Title
JP2004507521A5 (enExample)
RU2219167C2 (ru) N-замещенные аминотетралины как лиганды для рецептора y5 нейропептида y, полезные при лечении ожирения и других расстройств
JP2004517813A5 (enExample)
CA2632626C (en) Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection
JP2002541233A5 (enExample)
EA010852B1 (ru) Пиперидиновые соединения и фармацевтические композиции, их содержащие
CA2421114A1 (en) 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
JP2001526218A5 (enExample)
GB9900334D0 (en) Tricylic vascular damaging agents
JP2011527334A5 (enExample)
JP2003515526A5 (enExample)
HK1223819A1 (zh) 卤代烷基杂芳基苯甲酰胺化合物
KR900006318A (ko) 피페리디닐 벤즈이미다졸
RU2001132139A (ru) Имидазохинолины с сульфонамидными или сульфамидным замещением
JP2003509349A5 (enExample)
JPWO2020123827A5 (enExample)
JP2004527567A5 (enExample)
JP2004502732A5 (enExample)
CS243498B2 (en) Method of new beta-lactams production
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
JP2006513232A5 (enExample)
RU2003134629A (ru) Соединения цефема
JP2004529960A5 (enExample)
KR900018091A (ko) 진경제
DE60127535D1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation